The Latest Breaking News from Citi

Lilly's Eloralintide Plus Tirzepatide Produced 23.3% Weight Loss in Phase 2 Trial of Adults with Type 2 Diabetes

Lilly's eloralintide plus tirzepatide produced 23.3% weight loss vs 14.8% for tirzepatide alone in a Phase 2 diabetes trial. Here's the catch.

Medical Daily · Oct 2

Bitcoin price target: Why Citi raised its BTC USD forecast to $113,000 from $82,000 as the cryptocurrency rebounds

Bitcoin (BTC USD) price target: Citigroup has increased its 12-month Bitcoin price target from $82,000 to $113,000 due to favorable market conditions. The bank expects $5 billion in crypto investment product inflows over the next year as advisers increase allocations. Spot Bitcoin ETFs have started seeing renewed inflows after significant…

The Economic Times · Oct 1

Citi Just Upgraded Rocket Lab Stock. Here's Why.

Rocket Lab stock pushes higher on a bullish Citi note. Here’s why analyst John Godyn recommends buying RKLB shares.

Barchart · Oct 1

Citi Raises Estimates for Micron Ahead of Earnings. How to Play MU Stock Now.

Firm demand for DRAM and NAND finds the investment bank sounding more bullish about the memory giant.

Barchart · Sep 28

AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trials

The FDA approved Juvmo (tavapadon), AbbVie's once-daily Parkinson's pill. Here's how it works, which side effects trials found, and what to ask.

Medical Daily · Sep 28

Citi CEO Jane Fraser swears by Warren Buffett's golden rule for dealing with conflict at work: 'Never, ever respond to that email in anger'

Citigroup CEO Jane Fraser says Warren Buffett gave her two rules for handling conflict at work. The first? “You can always call them an a--hole tomorrow.”

Fortune · Sep 26

Ola Electric shares tumble 9% after 17% rally in 4 days. Why brokerages remain cautious

Ola Electric shares fell sharply on Friday, snapping a four-day winning streak as investors assessed the EV maker’s proposed rights issue and ongoing funding needs. Despite a recent recovery, the stock remains well below its peak. Brokerages including Citi and Kotak continue to maintain bearish views, citing operational and cash-burn…

The Economic Times · Sep 25

PB Fintech shares crash 36%, bloodbath wipes off Rs 31,426 cr from m-cap after IRDAI’s reform plans. What Citi and Jefferies are warning

PB Fintech shares crashed 36% to a 52-week low after IRDAI proposed an overhaul of insurance distributor commissions. The proposed norms could tighten distribution economics, with brokerages warning of lower commission income across key insurance segments.

The Economic Times · Sep 24

Coinbase Stock Surges as Crypto Giant Eyes Financial Markets Expansion

Coinbase stock is climbing as the crypto exchange pushes into derivatives, prediction markets, tokenized equities, and now IPO access for retail traders.

Barchart · Sep 23

Potential US tariffs threaten India's textile, apparel exports after Russia sanctions law: CITI report

Potential US tariffs could significantly harm India's textile and apparel exports. The industry body CITI is urging the government to engage with Washington urgently. This action is needed to protect Indian exporters from competitive disadvantages in the US market. A balanced trade agreement between India and the US is considered…

The Economic Times · Sep 19